Lars Fruergaard Jørgen

business executiveMale0.0Global Dominance: 0.00%

Lars Fruergaard Jørgen is the former CEO of Novo Nordisk, a leading Danish pharmaceutical company known for its groundbreaking weight-loss medications such as Ozempic and Wegovy. He stepped down in May 2023 amid a significant decline in the company's stock value, which had dropped over 50% in the previous year, due to increased competition and pressures on profit margins.

Power0

Reach0

Collect

Not in the pool (under ¢1).

Recent news mentions

Lars Fruergaard Jørgen announced his resignation as CEO of Novo Nordisk amid a significant drop in the company's stock value.

Crollo di Novo Nordisk, la concorrenza e le strategie di prezzo mettono a rischio il colosso dei farmaci per la perdita di peso

Corriere della Sera·

Italy· 2025-07-30

3.0

Also mentioned

Maziar Mike Doustdar